Top of this page
Skip navigation, go straight to the content

Our Company

Disease Areas

Our Science

UCB Worldwide

 Search

Our Products

Newsroom

Patients

Investors

FOLLOW US ON
© 2007 – 2019 UCB S.A., Belgium. All rights reserved.
Newsroom • Press Releases

Search Press releases


Transparency notification Vanguard Health Care Fund18 Oct 2019

Transparency notification Vanguard Health Care Fund

Read more
EVENITY® (romosozumab) Receives Positive CHMP Opinion for the Treatment of Severe Osteoporosis in Postmenopausal Women at High Risk of Fracture18 Oct 2019

EVENITY® (romosozumab) Receives Positive CHMP Opinion for the Treatment of …

Read more
Bimekizumab Phase 3 Psoriasis Study Meets All Endpoints, Achieving Significantly Greater Efficacy Versus Placebo and Ustekinumab17 Oct 2019

Bimekizumab Phase 3 Psoriasis Study Meets All Endpoints, Achieving Significantly …

Read more
Transparency notification BlackRock, Inc.11 Oct 2019

Transparency notification BlackRock, Inc.

Read more
UCB agrees to acquire Ra Pharmaceuticals: Joining forces to improve treatment options for people living with myasthenia gravis and other rare diseases10 Oct 2019

UCB agrees to acquire Ra Pharmaceuticals: Joining forces to improve …

Read more
UCB Showcases Wealth of new Psoriasis Research at EADV 201909 Oct 2019

UCB Showcases Wealth of new Psoriasis Research at EADV 2019

Read more


Stay up-to-date on the latest news and information from UCB